Rh alloimmunisation and anti-D immunoglobulin: when to give RhIG
Rh alloimmunisation needs an Rh D-negative mother, an Rh D-positive fetus and fetal cells in her blood. Anti-D immunoglobulin prevents it, but only in a woman who is not yet sensitised.
Explain how Rh alloimmunisation occurs and state when anti-D immunoglobulin is given to prevent it: 300 micrograms at 28 weeks, within 72 hours of an Rh-positive birth, and after sensitising events, and what changes once she is sensitised.
The short version
- Sensitisation needs an Rh D-negative mother, an Rh D-positive fetus and fetal red cells in her blood.
- The first baby is usually spared; memory cells then make IgG that crosses the placenta in a later Rh-positive pregnancy.
- Anti-D immunoglobulin is for the unsensitised: 300 micrograms at 28 weeks, within 72 hours of an Rh-positive birth, and after sensitising events.
- For loss or abortion before 12 weeks, ACOG now makes anti-D immunoglobulin optional; ectopic pregnancy still gets it.
- Once she is sensitised, anti-D immunoglobulin is no use: follow the antibody titre, then fetal middle cerebral artery Doppler once it reaches the critical titre.
How Rh alloimmunisation happens
A woman's first baby is born healthy. Her second baby develops severe anaemia before birth and swells with fluid. Nothing changed except the first pregnancy, so what did it leave behind? The answer is Rh alloimmunisation.
Red cells either carry the D antigen, making the person Rh D-positive, or they do not, making them Rh D-negative. The trouble starts when an Rh D-negative mother carries an Rh D-positive fetus.[3][4]
Fetal red cells can leak into her blood, mostly at delivery, but also after bleeding, miscarriage, an ectopic pregnancy, amniocentesis or abdominal trauma. As little as a tenth of a millilitre can be enough.[3]
Sensitisation, and why the second baby is the one affected
Her immune system sees the D antigen as foreign and makes anti-D antibodies. That is sensitisation, and it takes time, so the first baby is usually spared.[4][5]
Memory cells remain, making IgG, the antibody class that crosses the placenta. In a later Rh-positive pregnancy, that IgG coats the fetal red cells and macrophages destroy them.[3]
The result is haemolytic disease of the fetus and newborn: fetal anaemia and, in severe cases, hydrops fetalis.[3]
- ExposureRh D-positive fetal cells reach the Rh D-negative mother's blood.
- SensitisationShe makes anti-D antibodies; memory cells persist.
- Later Rh-positive pregnancyAnti-D IgG crosses the placenta and coats fetal red cells.
- HaemolysisMacrophages destroy the coated cells: fetal anaemia, and in severe cases hydrops fetalis.
Prenatal screening: blood group, Rh type and antibody screen
At the first prenatal visit, every woman has her blood group, Rh type and an antibody screen, the indirect Coombs test.[1][3]
If she is Rh D-negative and the screen is negative, she is unsensitised, and the screen is repeated between 24 and 28 weeks.[1][3]
Anti-D immunoglobulin (RhIG): the three-part rule
Prevention is anti-D immunoglobulin, and it works only in a woman who is not yet sensitised.[1][3] Its antibodies are thought to tag any fetal Rh-positive cells, so that macrophages clear them before her own immune system can respond.[3][5]
| Part | When | Detail |
|---|---|---|
| One | 28 weeks | 300 micrograms, intramuscularly |
| Two | Within 72 hours of delivery | If the newborn is Rh-positive |
| Three | After a sensitising event from 12 weeks on | Bleeding, miscarriage, an invasive procedure or trauma |
After delivery: fetal bleed testing and when it is not needed
After delivery, a rosette screen looks for a large fetal bleed. If it is positive, Kleihauer-Betke testing or flow cytometry measures it, because a large bleed needs more than one dose.[3]
No anti-D immunoglobulin is needed if the father is Rh-negative and paternity is certain, so the fetus is too, or if the newborn is Rh-negative.[3]
- First visit: antibody screen negative
- Repeat screen: negative
- 28 weeks: 300 micrograms of anti-D immunoglobulin
- Rh-positive baby delivered: second dose within 72 hours
- Rh-negative baby instead: no second dose
Already sensitised: the antibody titre and fetal MCA Doppler
Anti-D immunoglobulin is no use if she is already sensitised: it prevents sensitisation but cannot reverse it. Then we follow the antibody titre, and once it reaches the laboratory's critical titre, serial Doppler of the fetal middle cerebral artery looks for anaemia.[3]
Practice question
Original · USMLE styleA 31-year-old woman, gravida 3, para 2, is at 26 weeks of gestation. Her blood type is O, Rh D-negative, and her partner is Rh D-positive. Her two previous pregnancies ended in term vaginal deliveries; she did not receive anti-D immunoglobulin after the first delivery. At her first prenatal visit, the indirect Coombs test was positive. Antibody identification shows anti-D with a titer of 1:64 (the laboratory's critical titer is 1:16). Cell-free DNA testing of maternal blood shows an Rh D-positive fetus. Ultrasonography today shows appropriate fetal growth and normal amniotic fluid volume, with no ascites or hydrops.
Common questions
What is Rh alloimmunisation?
It is sensitisation of an Rh D-negative mother to the D antigen of an Rh D-positive fetus. Fetal red cells reach her blood, she makes anti-D antibodies, and in a later Rh-positive pregnancy that IgG can cross the placenta and destroy fetal red cells.
Why is the first baby usually spared?
Sensitisation takes time, so the first exposure is usually not enough to harm that baby. Memory cells remain and make IgG in a later pregnancy.
When is anti-D immunoglobulin (RhIG) given?
To an unsensitised Rh D-negative woman: 300 micrograms intramuscularly at 28 weeks, within 72 hours of delivery if the newborn is Rh-positive, and after sensitising events from 12 weeks on. Before 12 weeks it is optional after loss or abortion, but an ectopic pregnancy still gets it.
Is anti-D immunoglobulin needed if the baby or father is Rh-negative?
No. If the father is Rh-negative and paternity is certain, the fetus is too, and the postpartum dose is only for an Rh-positive newborn.
What is done once a woman is sensitised?
Anti-D immunoglobulin does not help. The antibody titre is followed, and once it reaches the laboratory's critical titre, serial Doppler of the fetal middle cerebral artery looks for anaemia.
Transcript
Read the full narration, by chapter719 words
0:00A healthy first baby, a severely anaemic second baby
A woman's first baby is born healthy. Her second baby develops severe anaemia before birth, and swells with fluid. Nothing changed except the first pregnancy. What did it leave behind? Today: how Rh alloimmunisation happens, and when anti-D immunoglobulin prevents
0:19The D antigen: Rh D-positive and Rh D-negative
it. Red cells either carry the D antigen, making the person Rh D-positive, or they do not, making them Rh D-negative. The trouble starts when an Rh D-negative mother carries an Rh D-positive fetus.
0:35Fetal red cells leak into the mother's blood
Fetal red cells can leak into her blood, mostly at delivery, but also after bleeding, miscarriage, an ectopic pregnancy, amniocentesis, or abdominal trauma. As little as a tenth of a millilitre can be enough.
0:50Sensitisation: anti-D antibodies and memory cells
Her immune system sees the D antigen as foreign and makes anti-D antibodies. That is sensitisation, and it takes time, so the first baby is usually spared. But memory cells remain, making IgG, the antibody class that crosses the placenta.
1:08The next pregnancy: IgG and haemolytic disease of the fetus and newborn
In a later Rh-positive pregnancy, that IgG coats the fetal red cells and macrophages destroy them. The result is haemolytic disease of the fetus and newborn: fetal anaemia, and in severe cases hydrops fetalis.
1:24First prenatal visit: blood group, Rh type, antibody screen
At the first prenatal visit, every woman has her blood group, Rh type, and an antibody screen, the indirect Coombs test. If she is Rh D-negative and the screen is negative, she is unsensitised, and the screen is repeated between 24 and 28 weeks.
1:44Prevention: how anti-D immunoglobulin works
Prevention is anti-D immunoglobulin, and it works only in a woman who is not yet sensitised. Its antibodies are thought to tag any fetal Rh-positive cells, so that macrophages clear them before her own immune system can respond.
2:00The three-part rule: 28 weeks, 72 hours, sensitising events
The rule has three parts. One: 300 micrograms, intramuscularly, at 28 weeks. Two: within 72 hours of delivery, if the newborn is Rh-positive. Three: after a sensitising event from 12 weeks on, such as bleeding, miscarriage, an invasive procedure, or trauma. For loss or abortion before 12 weeks, ACOG now makes it optional; ectopic still gets it.
2:30After delivery: rosette screen, Kleihauer-Betke, when it is not needed
After delivery, a rosette screen looks for a large fetal bleed; if positive, Kleihauer-Betke or flow cytometry measures it, because a large bleed needs more than one dose. None is needed if the father is Rh-negative, so the fetus is too, or if the newborn is Rh-negative.
2:49Already sensitised: titre and middle cerebral artery Doppler
It is no use if she is already sensitised; then we follow the antibody titre, and use Doppler of the fetal middle cerebral artery to detect anaemia.
3:00A worked example
An example. An Rh-negative woman screens negative at her first visit and at the repeat. She receives the dose at 28 weeks, and a second within 72 hours of delivering an Rh-positive baby. Had the baby been Rh-negative, no second dose.
3:19Your turn: practice question
Your turn. A 31-year-old woman, gravida three, para two, is at 26 weeks of gestation. She is blood group O, Rh D-negative, and her partner is Rh-positive. After her first delivery she was not given anti-D immunoglobulin. At her first visit, the indirect Coombs test was positive. Antibody identification shows anti-D with a titre of one in 64; the laboratory's critical titre is one in 16. Fetal cell-free DNA testing shows an Rh D-positive fetus. Ultrasonography today shows normal growth and amniotic fluid, with no hydrops. Which of the following is the most appropriate next step? A, anti-D immunoglobulin intramuscularly without delay. B, serial middle cerebral artery Doppler studies. C, anti-D immunoglobulin after delivery of an Rh-positive infant. D, Kleihauer-Betke testing of maternal blood now. E, intrauterine transfusion of the fetus now. Pause here and decide.
4:35The answer and why each option is right or wrong
A is out: she is already sensitised; anti-D prevents sensitisation but cannot reverse it. C is out for the same reason: giving it after delivery would not help. D is out: Kleihauer-Betke counts fetal cells to dose prophylaxis; it does not assess the fetus. E is out: intrauterine transfusion is for confirmed or strongly suspected fetal anaemia, not a high titre alone. So the answer is B. Her titre is above critical, so serial fetal middle cerebral artery Doppler looks for anaemia early.
5:13High-yield recap and next lesson
Three things to keep. One: sensitisation needs an Rh-negative mother, an Rh-positive fetus, and fetal cells in her blood. Two: anti-D immunoglobulin is for the unsensitised: at 28 weeks, within 72 hours of an Rh-positive birth, and after sensitising events, with early losses under 12 weeks now optional. Three: once she is sensitised, we follow the titre and the fetal Doppler. Next, antepartum bleeding.
Sources
Numbers in the text, e.g. [1], point here- ACOG Practice Bulletin No. 181, Prevention of Rh D Alloimmunization (Aug 2017).
- ACOG Clinical Practice Update 2024: Rh testing and RhIG before 12 0/7 weeks (Obstet Gynecol 2024;144:e140-e143, PMID 39255498).
- Red blood cell alloimmunization and pregnancy: diagnosis and management, Pregnancy (Hoboken) 2025. europepmc.org/article/PMC/PMC13344805
- Clinical value of different anti-D immunoglobulin strategies for preventing Rh HDFN: network meta-analysis, PLoS One 2020. europepmc.org/article/PMC/PMC7067404
- Wikipedia. Rh disease; Rho(D) immune globulin (secondary sources).
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, outlined, resized): "Pregnancy", "Fetus in utero", "Placenta", "Immunoglobulins - IgG", "Syringe", "Baby girl", "Doppler ultrasound examination". Red blood cell (item 442) and macrophage (item 311): NIAID NIH BioArt (public domain). The D antigen marks, antibody glyphs, lab slip, rule card, timeline, titre curve, Doppler waveform (schematic), cards and all handwriting are drawn in code (original). No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-CK-OBGYN-009.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01Prenatal screening timeline: what is done when in pregnancy5:23
- EP 02Ectopic pregnancy: beta-hCG, ultrasound, methotrexate vs surgery5:53
- EP 03Adnexal torsion: why normal Doppler does not rule it out5:31
- EP 04Gestational diabetes: screening, diagnosis and management5:25
- EP 05Preeclampsia: criteria, severe features, magnesium and delivery timing5:43
- EP 06Rh alloimmunisation and anti-D immunoglobulin: when to give RhIG5:49
- EP 07Placenta previa vs placental abruption5:43
- EP 08PROM vs PPROM: diagnosis and management by gestational age5:59
- EP 09Fetal heart rate decelerations: early, variable and late5:46
- EP 10Postpartum hemorrhage: the 4 Ts and first response5:46